AMC is heating up, and the chart is screaming potential! Let’s dive into the current price action and why this meme stock might be gearing up for a move.
Price Action & Technicals
AMC’s daily chart is teasing a breakout. The stock is currently trading at $2.67, hugging a key resistance around $2.70-$2.80. We’ve seen it consolidate tightly after a month of grinding between $2.61-$2.92. The 50-day moving average (~$3.00) is looming as the next hurdle, and a strong close above $2.80 could spark bullish momentum. Volume has been picking up, hinting buyers are stepping in. The last notable “squeeze” on May 13, 2024, rocketed AMC to $11.87 from similar consolidation levels. Looking at the chart, $5.80 (a strong high from late 2024) is a realistic first target, but a squeeze could push higher if momentum kicks in—who knows how high?
Earnings Buzz on X
The upcoming Q1 2025 earnings on May 7, 2025, are generating chatter on X. @Ryan__Rigg
posted about the earnings date, signaling retail excitement. @StockRetail
highlighted AMC’s improving revenue and low price-to-sales ratio (~0.23), suggesting Q2 could surprise given strong box office trends. biotech_moose
is hyped about the box office results fueling a solid earnings call. Even ceoadam
’s hint at potential news (per @xMarketNews
) has retail investors speculating about mergers or acquisitions. The sentiment is bullish, and options activity is ramping up, with @simulationchess
noting heavy call buying at $3-$5 strikes, which could trigger a gamma squeeze if earnings deliver.
FOMC & Trump’s Rate Cut Push
The FOMC meeting on May 6-7, 2025, is another catalyst to watch. Trump’s vocal push for rate cuts could pressure the Fed, especially with markets pricing only a 9% chance of a 25 bps cut []. A dovish surprise or Trump-driven optimism could boost risk assets like AMC, especially given its meme stock sensitivity. Lower rates could fuel retail FOMO, potentially igniting a short squeeze—13.94% of the float is shorted []. While nobody can predict the ceiling, the May 2024 run to $11.87 shows what’s possible when the stars align.
Squeeze Potential & Strategy
With earnings, FOMC, and Trump’s influence converging, AMC could see a volatile move. Options buying is picking up, and a breakout above $2.80-$3.00 could trigger a gamma squeeze as dealers hedge ITM calls. First target: $5.80. If momentum builds, $11.87 or beyond isn’t out of the question, but don’t get greedy—$1000 dreams are fun, but locking in profits is smarter. Always use tight stops and position sizing. This is a meme stock, so volatility is wild, and risk management is non-negotiable.
Final Thoughts
AMC’s daily chart is coiling for a breakout, earnings hype is real, and FOMC plus Trump’s rate cut narrative could light a fire. Whether it’s a quick scalp to $5.80 or a squeeze to $11.87+, the setup is intriguing. But stay disciplined—take profits when you’ve got them, and never bet the farm.
This is my personal opinion and analysis, not trading advice. Always do your own research and manage your risk carefully.
Price Action & Technicals
AMC’s daily chart is teasing a breakout. The stock is currently trading at $2.67, hugging a key resistance around $2.70-$2.80. We’ve seen it consolidate tightly after a month of grinding between $2.61-$2.92. The 50-day moving average (~$3.00) is looming as the next hurdle, and a strong close above $2.80 could spark bullish momentum. Volume has been picking up, hinting buyers are stepping in. The last notable “squeeze” on May 13, 2024, rocketed AMC to $11.87 from similar consolidation levels. Looking at the chart, $5.80 (a strong high from late 2024) is a realistic first target, but a squeeze could push higher if momentum kicks in—who knows how high?
Earnings Buzz on X
The upcoming Q1 2025 earnings on May 7, 2025, are generating chatter on X. @Ryan__Rigg
posted about the earnings date, signaling retail excitement. @StockRetail
highlighted AMC’s improving revenue and low price-to-sales ratio (~0.23), suggesting Q2 could surprise given strong box office trends. biotech_moose
is hyped about the box office results fueling a solid earnings call. Even ceoadam
’s hint at potential news (per @xMarketNews
) has retail investors speculating about mergers or acquisitions. The sentiment is bullish, and options activity is ramping up, with @simulationchess
noting heavy call buying at $3-$5 strikes, which could trigger a gamma squeeze if earnings deliver.
FOMC & Trump’s Rate Cut Push
The FOMC meeting on May 6-7, 2025, is another catalyst to watch. Trump’s vocal push for rate cuts could pressure the Fed, especially with markets pricing only a 9% chance of a 25 bps cut []. A dovish surprise or Trump-driven optimism could boost risk assets like AMC, especially given its meme stock sensitivity. Lower rates could fuel retail FOMO, potentially igniting a short squeeze—13.94% of the float is shorted []. While nobody can predict the ceiling, the May 2024 run to $11.87 shows what’s possible when the stars align.
Squeeze Potential & Strategy
With earnings, FOMC, and Trump’s influence converging, AMC could see a volatile move. Options buying is picking up, and a breakout above $2.80-$3.00 could trigger a gamma squeeze as dealers hedge ITM calls. First target: $5.80. If momentum builds, $11.87 or beyond isn’t out of the question, but don’t get greedy—$1000 dreams are fun, but locking in profits is smarter. Always use tight stops and position sizing. This is a meme stock, so volatility is wild, and risk management is non-negotiable.
Final Thoughts
AMC’s daily chart is coiling for a breakout, earnings hype is real, and FOMC plus Trump’s rate cut narrative could light a fire. Whether it’s a quick scalp to $5.80 or a squeeze to $11.87+, the setup is intriguing. But stay disciplined—take profits when you’ve got them, and never bet the farm.
This is my personal opinion and analysis, not trading advice. Always do your own research and manage your risk carefully.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.